Skip to content
healthcare.dev

Erlotinib

NDC 0093-7664, Erlotinib, tablet, film coated, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-7664
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091059
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERLOTINIB HYDROCHLORIDE150 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0093-7664-560009376645630 TABLET, FILM COATED in 1 BOTTLE (0093-7664-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d97f401-4853-4a9a-907d-21e8a4d16088

Use it

Look up 0093-7664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-7664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.